![William Mezzanotte](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William Mezzanotte
Director Técnico/Científico/I+D en CSL LIMITED .
Cargos activos de William Mezzanotte
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CSL LIMITED | Director Técnico/Científico/I+D | 01/10/2018 | - |
Oficial de Recursos Humanos | 01/10/2018 | - | |
University City Science Center
![]() University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | Director/Miembro de la Junta | 19/06/2020 | - |
Historial de carrera de William Mezzanotte
Antiguos cargos conocidos de William Mezzanotte.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BELLUS HEALTH | Director/Miembro de la Junta | 24/03/2021 | 01/01/2023 |
C.H. Boehringer Sohn AG & Co. KG
![]() C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Corporate Officer/Principal | 01/04/2015 | 01/04/2017 |
ASTRAZENECA PLC | Corporate Officer/Principal | 01/06/2012 | 01/03/2015 |
CSL Behring LLC
![]() CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Director Técnico/Científico/I+D | 01/04/2017 | - |
Corporate Officer/Principal | - | - |
Formación de William Mezzanotte.
Villanova University | Undergraduate Degree |
University of Pennsylvania | Doctorate Degree |
The Johns Hopkins University | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Reino Unido | 2 |
Australia | 2 |
Operativa
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 2 |
Sectorial
Health Technology | 6 |
Consumer Services | 4 |
Miscellaneous | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
CSL LIMITED | Health Technology |
Empresas privadas | 4 |
---|---|
C.H. Boehringer Sohn AG & Co. KG
![]() C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
University City Science Center
![]() University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | Miscellaneous |
BELLUS Health, Inc.
![]() BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
CSL Behring LLC
![]() CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
- Bolsa de valores
- Insiders
- William Mezzanotte
- Experiencia